Monitor the special meeting vote results on December 2, 2026; approval of the blank cheque preferred share authorization and share split authorization would give the Board more flexibility for future capital raising and strategic transactions, but no immediate financial impact.
Price Chart
Executive Summary
Medicus Pharma Ltd. is holding a special meeting on December 2, 2026, to seek shareholder approval for three proposals: (1) creating a new class of unlimited 'blank cheque' Class A Preferred Shares to provide flexibility for future financings and acquisitions, (2) authorizing a share split of up to 50:1 (which would substantially reverse the 1:50 consolidation effected on October 12, 2026), and (3) adjourning the meeting if needed. The Board unanimously recommends a 'FOR' vote on all proposals. The filing is a routine governance proxy with no executive compensation, director election, or shareholder proposal items.
Key Facts
- Special meeting on December 2, 2026, to vote on three proposals: creation of blank cheque preferred shares, authorization of a share split up to 50:1, and adjournment.
- The company has 1,899,338 common shares outstanding as of the October 28, 2026 record date, with 201 shareholders of record.
- On October 12, 2026, the company effected a 50:1 reverse stock split to regain Nasdaq minimum bid price compliance.
- The proposed share split (up to 50:1) would substantially reverse the October 12 consolidation.
- The Board has no present intention to issue the Class A Preferred Shares and the proposal is not in response to any takeover effort.
- Proxy solicitation agent Sodali & Co will receive fees up to C$45,000 for services.
- Insider ownership: CEO Dr. Raza Bokhari holds 5.3%; all officers and directors as a group hold 14.4%.
Financial Impact
No financial figures disclosed; the proposals authorize future actions but no issuance or split has been executed. Proxy solicitation fees up to C$45,000.
Risk Factors
- If the share split is implemented at or near the maximum 50:1 ratio, the bid price could fall below the $1.00 Nasdaq minimum bid price requirement, risking delisting.
- The creation of blank cheque preferred shares could be used as an anti-takeover device, potentially diluting common shareholder rights.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001062993-26-005627 |
| Document: 0001062993-26-005627-index-headers.html | 0001062993-26-005627 |
| Document: 0001062993-26-005627-index.html | 0001062993-26-005627 |
| Document: 0001062993-26-005627.txt | 0001062993-26-005627 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | DEF 14A | $2.17 | awaiting T+1 | awaiting T+1 | $1.88 (−13.36%) |
Oct 23, 2026 8d ago | 8-K | $2.51 $2.45 | ▼ −2.39% | ▼ −2.95% | $1.88 (−25.10%) |
Oct 16, 2026 16d ago | 8-K | $2.66 $2.72 | ▲ +2.45% | ▲ +2.11% | $1.88 (−29.19%) |
Oct 16, 2026 16d ago | SC 13G/A | $2.66 $2.72 | ▲ +2.45% | ▲ +2.11% | $1.88 (−29.19%) |
Oct 7, 2026 25d ago | 8-K | $0.1019 $0.0921 | ▼ −9.62% | ▼ −10.22% | $1.88 (+1744.95%) |
Sep 14, 2026 6w ago | 8-K | $0.1593 $0.1521 | ▼ −4.52% | ▼ −4.06% | $1.88 (+1080.16%) |
Sep 11, 2026 7w ago | 8-K | $0.1626 $0.1593 | ▲ +2.03% | ▲ +1.58% | $1.88 (−1056.21%) |
Sep 10, 2026 7w ago | Press Release | $0.1614 $0.1626 | ▲ +0.74% | ▼ −0.11% | $1.88 (+1064.81%) |
Sep 3, 2026 8w ago | 8-K | $0.1705 $0.1720 | ▲ +0.88% | ▲ +1.27% | $1.88 (+1002.64%) |
Jul 16, 2026 15w ago | Press Release | $0.4060 $0.3758 | ▼ −7.44% | ▼ −6.45% | $1.88 (+363.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers